Next Article in Journal
Investigation into the Optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer
Next Article in Special Issue
Physical Differences between Man-Made and Cosmic Microwave Electromagnetic Radiation and Their Exposure Limits, and Radiofrequencies as Generators of Biotoxic Free Radicals
Previous Article in Journal
MR-LINAC-Guided Adaptive Radiotherapy for Gastric MALT: Two Case Reports and a Literature Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Radiation
Volume 2
Issue 3
10.3390/radiation2030020
Review Report
radiation-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Commentary
Peer-Review Record

COVID-19 Update: The Golden Time Window for Pharmacological Treatments and Low Dose Radiation Therapy

Radiation 2022, 2(3), 268-272; https://doi.org/10.3390/radiation2030020
by Seyed Mohammad Javad Mortazavi 1,†, B. F. Bahaaddini Baigy Zarandi 2,†, Abdollah Jafarzadeh 3, S. Alireza Mortazavi 4 and Lembit Sihver 5,6,7,*
Reviewer 1: Anonymous
Reviewer 2:
Sylwester Sommer
Radiation 2022, 2(3), 268-272; https://doi.org/10.3390/radiation2030020
Submission received: 18 May 2022 / Revised: 14 July 2022 / Accepted: 15 July 2022 / Published: 20 July 2022
(This article belongs to the Special Issue Feature Papers of Radiation 2022)

Round 1

Reviewer 1 Report

In the last 2 paragraphs (lines 84-90 and 91-104) adding some of quantitative values may make your statements more convincing. 

Author Response

Thank you very much for your valuable comments. We have added a simple summary, a conclusion, and we have added some more information in the last 2 paragraphs (lines 84-90 and 91-104 to may make our statements more convincing.  

Reviewer 2 Report

The manuscript is commentary but at the beginning I did not understand of what commentary it is. Now I think I understood the goal of the commentary, but in both situation: I really understood the goal or I am wrong, the goal of commentary should be stated clearly (and in the abstract as well). The commentary is for „Radiation” because authors published the article about Covid and LDRT in the Radiation in 2021. And the commentary is because since then several papers regarding pharmacological treatment of COVID-19 have been published. In these papers the considerations on the effectiveness of the pharmacological therapy has been shown as well as treatment influence on the mutation and evolution of the virus. The non-virus pressure LDRT is confronted with pharmacological treatment and authors shows LDRT advantages but I as a reader have impression the its virus mutation pressure-free character is the LDRT main advantage and this is not true. I would put accents slightly different showing that there is a lot of advantages of LDRT and one of them is its pressure-free quality.

The rest is interesting and perfect for me, no other remarks. I like the figures very much, as they are clear and colourful.

Author Response

Thank you very much for your valuable comments. We have added an abstract, a conclusion and a summary. We have tried to make is clearer that the non-virus pressure LDRT is confronted with pharmacological treatment and there is a lot of advantages of LDRT and one of them is its pressure-free quality.

Back to TopTop